EVAS THERAPEUTICS, LLC.

Company Information

Company Name
EVAS THERAPEUTICS, LLC.
Address
613 HUNTLEY HEIGHTS DRIVE
BALLWIN, MO, -
Phone
n/a
URL
n/a
DUNS
143727191
Number of Employees
n/a
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$320,133.00
2
SBIR Phase II
$1,365,616.00
1

Award List

  1. Novel Recombinant Anticoagulant Proteins

    Amount: $152,652.00

    DESCRIPTION (provided by applicant): Phase I: Clot formation in the blood vessel (thrombosis) causes a broad range of serious clinical conditions, such as unstable angina, acute myocardial infarction, ...

    SBIR Phase I 2005 Department of Health and Human Services
  2. Pharmacologic treatment of thromboembolism

    Amount: $167,481.00

    DESCRIPTION (provided by applicant): Thromboembolic disorders are major causes of morbidity and mortality in the Western societies. Anticoagulants are pivotal agents in the prevention and treatment of ...

    SBIR Phase I 2009 Department of Health and Human Services
  3. Novel antithrombotic agents to prevent hemodialysis vascular access failure

    Amount: $1,365,616.00

    DESCRIPTION (provided by applicant): Currently, more than 60 % of end-stage renal diseases patients who require chronic hemodialysis are accessed through a native arteriovenous fistula (AVF) or synthe ...

    SBIR Phase II 2012 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government